Results 111 to 120 of about 10,181,415 (248)

Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.

open access: yesPLoS ONE, 2020
HIV-associated/epidemic Kaposi's sarcoma (EpKS) is an AIDS-defining angio-proliferative malignancy. It can be treated with antiretroviral therapy (ART) alone or with ART plus cytotoxic chemotherapy.
Owen Ngalamika   +6 more
doaj   +1 more source

Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro   +14 more
wiley   +1 more source

Severe non AIDS-related events observed during the follow-up (overall results and stratified by immunological response at year 1).

open access: yes, 2015
List of abbreviations: AIDS, acquired immunodeficiency syndrome; eGFR, estimated glomerular filtration rate; INR, immunological non-responders; IR, Immunological responders.Severe non AIDS-related events observed during the follow-up (overall results and
Massimo Di Pietro (237801)   +12 more
core   +1 more source

Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients

open access: yesPLoS ONE, 2010
Treatment of HIV-infected patients with interleukin-2 (IL-2) produces significant increases in CD4 T cell counts; however an associated qualitative improvement in cells function has yet to be conclusively demonstrated. By measuring mycobacterial killing activity, we evaluated IL-2-mediated functional immune enhancement ex vivo in immunological non ...
Francesca Sabbatini   +8 more
openaire   +4 more sources

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu   +10 more
wiley   +1 more source

Baltic immunological assembly Abstracts

open access: yes, 1992
Available from Latvian Academic Library / LAL - Latvian Academic ...
Baltic Immunological Society, Riga (Latvia)
core  

Minimal Important Change and Minimal Clinically Important Difference in Pain and Function With Exercise in Hip Osteoarthritis

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this study was to estimate the minimal important change (MIC) and minimal clinically important difference (MCID) for pain and physical function in individuals with hip osteoarthritis (OA) following a physiotherapist‐guided exercise intervention.
Yareni Guerrero   +8 more
wiley   +1 more source

Minutes of the 58th meeting of the Council of the International Union of Immunological Societies

open access: yes, 2011
Meeting minutes of the 58th meeting of the Council of the International Union of Immunological Societies held on June 23rd, 2011 in Washington, D.C ...
International Union of Immunological Societies
core  

Formal and Informal Social Care in People With Rheumatic and Musculoskeletal Diseases: A Cross‐Sectional Multicenter Survey

open access: yesArthritis Care &Research, EarlyView.
Objective Rheumatic and musculoskeletal diseases (RMDs) are leading causes of physical disability, necessitating support with activities of daily living. This study describes social care received by patients with RMDs in two disparate regions of England: Salford (urban) and Norfolk (rural).
Mehreen Somro   +6 more
wiley   +1 more source

Barriers to bowel scope (flexible sigmoidoscopy) screening: a comparison of non-responders, active decliners and non-attenders [PDF]

open access: yes, 2018
Background: Participation in bowel scope screening (BSS) is low (43%), limiting its potential to reduce colorectal cancer (CRC) incidence and mortality.
Kerrison, Robert S   +23 more
core   +1 more source

Home - About - Disclaimer - Privacy